Connect with us

Hi, what are you looking for?

Digital Health

Akili Strikes $37.5M Licensing Deal for Another Game-Based Treatment

The company is licensing out technology from Australian digital health company TALi Digital to improve attention in early childhood.

Akili Strikes $37.5M Licensing Deal for Another Game-Based Treatment

After getting FDA clearance for its game to improve attention in kids with ADHD, digital health company Akili Interactive is looking to bring another to the market.

The Boston-based company struck a $37.5 million licensing deal with Australian digital health company TALi Digital to bring its game-based treatment to the U.S.

Although the companies take a similar approach, TALi’s game targets a slightly younger demographic. Akili’s game is cleared for use by children ages 8 to 12, and TALi’s  is designed for kids ages 3 to 8.

“Focused on early childhood intervention targeting attention, TALi’s impressive technology is an ideal addition to Akili’s portfolio. We are committed to changing the way people think about medicine, and strategic agreements like this will allow us to expand our vision to treat cognitive impairments in entirely new ways and usher in the next generation of digital therapeutics,” Akili CEO Eddie Martucci said in a news release.

Akili plans to use its recent experience to run clinical trials of TALi’s technology for pediatric ADHD, with the goal of getting FDA clearance for this indication. It will head up commercialization efforts per its agreement with TALi.

Seen on MedCity News: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News


PocDoc, the digital health platform and personal diagnostics provider, has launched what it says is a world-first smartphone-based test for cardiovascular disease.


Focused on connecting startups in the Medtech industry with potential investors, this can't miss event features the globe's most promising companies


The technology could greatly aid spinal surgeons in planning surgical interventions in advance.   


Emerging HealthTech company, Stasis Labs, Inc. intends to bridge the gap between clinicians and their patients with an all-in-one FDA-cleared hardware and software solution,...

You May Also Like


Today & Tomorrow: Digital Solutions in HealthTech Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare...


In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...


Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...


The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.